Zephyr Surgical Implants
Zephyr Surgical Implants is a privately held Swiss medical device company (founded 1998, manufacturing since 2007) that designs and sells biocompatible silicone urological and gender-affirming surgical implants — including artificial urinary sphincters and penile prostheses — directly to hospitals and surgeons across Europe, India, and LATAM.
- Company typePrivate
- Founded1998
- HeadquartersLes Acacias, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Zephyr Surgical Implants does
Zephyr Surgical Implants (operating as ZSI Surgical Implants S.R.L.) is a privately held Swiss medical device company founded in 1998 and manufacturing since 2007, headquartered in Les Acacias (Geneva) with additional offices in Lyon, France and Chennai, India. The company designs and manufactures biocompatible silicone implants for urology, andrology, and gynaecology, with a core portfolio spanning artificial urinary sphincters (ZSI 375 PF), malleable and inflatable penile implants (ZSI 100, ZSI 100 CF, ZSI 475), specialized implants for female-to-male gender-affirming surgery (ZSI 475 FTM, ZSI 100 FTM, ZSI 100 D4 for metoidioplasty), and vaginal expanders for cis and trans women (ZSI 200 NS). ZSI positions itself as the only European manufacturer of artificial urinary sphincters and of implants specifically engineered for transgender anatomy rather than repurposed male implants.
The company's revenue model is direct-to-provider B2B medical device sales on a quote-based, one-time-purchase basis. Go-to-market is hybrid: direct sales via regional sales managers (International, Italy, India) are combined with country-specific distributors across LATAM (Medinistros SAS Colombia, Neomed SAS Uruguay, Urotec Medical Costa Rica, Tonallidechile Chile) and a co-development/training ecosystem anchored at reference hospitals such as Lyon Sud (France), Hôpital Foch (France), Vithas Nisa Pardo (Spain), New Victoria Hospital (UK), and Kamol Cosmetic Hospital (Thailand). Demand generation relies heavily on medical congress participation (USICON, WPATH), recurring surgeon training workshops, localized content blogs (Trans, India, LATAM, Middle East), and social/LinkedIn presence rather than paid acquisition. Customer segments split between male urinary incontinence and erectile dysfunction (established) and transgender-affirming surgical applications (growth engine), with gynaecology as a secondary vertical.
Operationally, ZSI serves 15+ countries across Europe, South Asia, LATAM, and the Middle East. The company is independently owned with no disclosed external funding, parent, or venture backing; no public-company financials, revenue figures, or headcount details are disclosed beyond the firmographic band of 11–50 employees. Distribution strategy has shifted in 2024 from distributor-led to direct sales in India, indicating an intentional move toward capturing higher per-unit economics in a high-volume emerging market. The product portfolio remains hardware-centric with no AI/ML capabilities, software offerings, or digital surgical-assistance products evidenced in the source data.
Zephyr Surgical Implants firmographics
Firmographics- Name
- Zephyr Surgical Implants
- Legal name
- ZSI Surgical Implants S.R.L.
- Website
- https://zsimplants.ch
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Zephyr Surgical Implants is a privately held Swiss medical device company (founded 1998, manufacturing since 2007) that designs and sells biocompatible silicone urological and gender-affirming surgical implants — including artificial urinary sphincters and penile prostheses — directly to hospitals and surgeons across Europe, India, and LATAM.
- Ownership category
- akta.pro rank
Where Zephyr Surgical Implants is headquartered
LocationHeadquarters
- HQ city
- Les Acacias
- HQ country
- Switzerland
- HQ region
- Europe
Offices3 records
Markets served
Zephyr Surgical Implants business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: ZSI manufactures and sells surgical implants (artificial urinary sphincters, penile implants, vaginal expanders) to hospitals and surgeons for urological procedures, gender-affirming surgeries, and gynaecological applications. Revenue is generated through direct sales to healthcare facilities and through regional distributors.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Zephyr Surgical Implants product offering
Product offeringCore offering
Zephyr Surgical Implants (ZSI) is a Swiss medical device manufacturer that designs and produces surgical implants for urology, andrology, and gynaecology. Its product range includes artificial urinary sphincters, inflatable and malleable penile implants (including variants specifically engineered for FTM and MTF gender-affirming surgery), and vaginal expanders for cis and trans women. The company sells these implants directly to hospitals and surgeons and through regional distributors.
Product overview
Zephyr Surgical Implants is a Swiss medical device company manufacturing urological and gender-affirming surgical implants. The product portfolio consists of: (1) Urinary incontinence solutions including the ZSI 375 PF artificial urinary sphincter; (2) Erectile dysfunction treatments including the ZSI 475 inflatable penile implant and ZSI 100 malleable penile implants (standard and soft variants); (3) Gender reassignment implants for trans men including the ZSI 475 FTM inflatable and ZSI 100 FTM malleable penile implants for phalloplasty, and the ZSI 100 D4 for metoidioplasty; (4) Vaginal expanders for both cis and trans women (ZSI 200 NS); and (5) Surgical instrument kits. The company is the only European manufacturer of artificial urinary sphincters and gender reassignment penile implants. Founded in 2007, the company has over 25 years of experience in urology-andrology.
Differentiator
Problem solved
Functional benefit
Products and services
- ZSI 375 PF Artificial Urinary Sphincter An artificial urinary sphincter device that mimics the natural function of the urinary sphincter, allowing male patients to regain bladder control for the treatment of urinary incontinence. Sold to hospitals and surgeons performing urological procedures.
- ZSI 475 Inflatable Penile Implant A hydraulic inflatable penile implant providing a durable solution for erectile dysfunction, with an advanced design aimed at natural-feeling erections. Sold to hospitals and surgeons for implantation in men with ED.
- ZSI 100 Malleable Penile Implant (Semi-Rigid) A semi-rigid malleable penile implant made of biocompatible silicone, providing consistent rigidity while allowing manual positioning, used for the treatment of erectile dysfunction. Sold to hospitals and surgeons.
- ZSI 100 CF Malleable Penile Implant (Soft) A soft malleable penile implant variant offering enhanced comfort compared with the semi-rigid model, designed for the treatment of erectile dysfunction. Sold to hospitals and surgeons.
- ZSI 475 FTM Inflatable Penile Implant for Phalloplasty An inflatable penile prosthesis specifically designed for female-to-male trans patients who have undergone phalloplasty, featuring a pump inserted into the scrotum and secure attachment to the pubic bone using Mitek anchors. Sold to hospitals and surgeons performing gender-affirming surgery.
- ZSI 100 FTM Malleable Penile Implant for Phalloplasty A semi-rigid malleable penile implant made of biocompatible silicone, specifically engineered for female-to-male trans anatomy following phalloplasty. Includes a plate fixed to the pubic bone with sutures, central body, and penile portion, with a narrow version available for narrower phalloplasties. Sold to hospitals and surgeons.
- ZSI 100 D4 Malleable Penile Implant for Metoidioplasty A semi-rigid malleable penile implant specifically designed for metoidioplasty procedures, preventing tissue retraction after surgery while maintaining functionality. Sold to hospitals and surgeons performing gender-affirming surgery for trans men.
- ZSI 200 NS Vaginal Expander (Cis Woman) A vaginal expander device designed for cisgender women, used in gynaecological procedures and post-operative care. Sold to hospitals and gynaecological surgeons.
- ZSI 200 NS Vaginal Expander (Trans Woman) A vaginal expander device designed for trans women, used in vaginoplasty procedures and post-operative dilation support following gender-affirming surgery. Sold to hospitals and gender-affirming surgeons.
- Kits for Implant Procedures Surgical instrument kits manufactured and supplied by ZSI France, providing the necessary tools for surgeons performing ZSI device implantations. Sold to hospitals and surgeons.
Quantifiable outcome
- Patients report satisfaction with implants and recommend ZSI products
- +1 more outcomes
Companies that use Zephyr Surgical Implants
Customer profileNamed customers11 records
Segments5 records
Ideal customer profiles3 records
Zephyr Surgical Implants technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Zephyr Surgical Implants partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and regional.
- Lyon Sud Hospital (CHU de Lyon)coreDr. Nicolas Morel-Journel's team at Lyon Sud Hospital organizes three-day workshops on gender reassignment surgical procedures with ZSI, hosting international surgeons for reconstructive and prosthetic surgery training.
- Kamol Cosmetic Hospital, BangkokcoreCollaboration between ZSI and Kamol Cosmetic Hospital for FTM surgeries. Blanche Delacourt, International Sales Manager, visited Bangkok to strengthen this partnership.
- Medinistros SAS (Colombia)coreOfficial ZSI distributor in Colombia. Daniel Posada and Sandra Caseres coordinate logistics and surgical support for ZSI implant procedures at Colombian hospitals including Hospital Universitario San Ignacio.
- CEPHLAN - ZSI IndiacoreZSI India operation launched at USICON 2024 in Chennai, transitioning to direct sales after ten years via a distributor. In charge of sales and surgical support in Indian market.
- Vithas Nisa Pardo Hospital, MadridcoreSpanish hospital where ZSI 475 FTM inflatable implants are regularly implanted. Dr. Ignacio Moncada performed first ZSI FTM implantation in Spain at this hospital.
- Hôpital Foch, Paris-SuresnescoreCentre of excellence for genital surgeries for trans men. Dr. François-Xavier Madec and Dr. Aurélie Schirmann specialize in gender-affirming procedures with ZSI implants.
- New Victoria Hospital, LondoncoreUK hospital with gender dysphoria surgical service where ZSI 100 FTM malleable implant was implanted in May 2022.
- Neomed SAS (Uruguay)regionalDistributor for Uruguay, facilitating first ZSI 375 PF Artificial Urinary Sphincter implantation at COMEPA Hospital.
- Urotec Medical (Costa Rica)regionalDistributor in Costa Rica facilitating ZSI 375 PF Artificial Urinary Sphincter implantation at Hospital de Alajuela.
- Tonallidechile (Chile)regionalDistributor in Chile supporting Dr. Victor Venegas with ZSI 100 malleable penile prosthesis implantation.
- Dr. Nicolas Morel-JournelcoreInternationally recognized French surgeon for reconstructive surgery for trans patients. Organizes workshops and collaborates on phalloplasty surgeries across LATAM including Bogotá.
- Blanche Delacourt (International Sales Manager)coreInternational Sales Manager who travels to establish partnerships with hospitals like Kamol Cosmetic Hospital in Bangkok and manages surgeon relationships globally.
- Shilpa PatangecoreSales Manager and surgical support representative for ZSI India, integrated into Indian branch in 2024.
Scale indicators3 records
Recent moves8 records
Expansion highlights6 records
Zephyr Surgical Implants competitors and assessment
Company assessmentBroad incumbents
- Boston Scientific: Global medtech incumbent whose Men's Health portfolio (AMS 800 artificial urinary sphincter, AMS 700 inflatable penile implant) directly competes with ZSI's ZSI 375 PF and ZSI 475. Much larger, US-listed, with broader geographic and clinical reach.
- Coloplast: Danish medtech incumbent with the Titan touch inflatable penile implant, directly competing with ZSI's ZSI 475. Larger scale, established US presence, and a dedicated Men's Health commercial organization.
- Cook Medical: Large privately held medtech with a significant urology franchise (stents, catheters, surgical devices), making it an incumbent comparator for ZSI on hospital contracts even though it does not focus on penile implants.
- Integra LifeSciences: Broad medtech incumbent with surgical and urology-adjacent franchises, relevant as a comparator on medtech manufacturing scale, regulatory infrastructure, and specialty distribution capabilities.
Direct peers
- Rigicon: US-based specialist in penile implants (Infla10 and Rigi10 malleable/inflatable prostheses), making it the closest direct peer to ZSI's penile implant portfolio. Similar size and product focus, with US FDA clearances.
- Promedon: Argentina-headquartered urology and urogynecology implant specialist active across LATAM, comparable to ZSI in geographic orientation and product category. Overlapping with ZSI in sling and pelvic-floor implant niches.
- ZSI 100 (Shah Silicone): Indian manufacturer of silicone penile implants, the closest regional direct competitor to ZSI in the South Asian market and a reason ZSI transitioned to direct sales in India in 2024.
- Silimed: Brazilian silicone implant manufacturer with a urology and aesthetics portfolio, comparable to ZSI on materials expertise (medical-grade silicone) and Latin American distribution footprint.
- Lepu Medical: Chinese medical device company with a penile implant line, comparable to ZSI as a regional specialist challenger to Boston Scientific and Coloplast in Asia.
Others
- KARL STORZ: Global leader in endoscopic and surgical instruments used in urology and gender-affirming surgery. Comparable as an ecosystem supplier whose visualization/instrument platforms are used alongside ZSI implants in the operating room.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Zephyr Surgical Implants social profiles
Digital presenceZephyr Surgical Implants financial estimates
Financial estimateRevenue estimate
Valuation estimate
Zephyr Surgical Implants leadership team
Management profileNumber of profiles
Profiles1 record
Zephyr Surgical Implants subsidiaries and ownership
Company hierarchySubsidiaries1 record
Zephyr Surgical Implants funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Zephyr Surgical Implants M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Zephyr Surgical Implants
What does Zephyr Surgical Implants do?
Zephyr Surgical Implants (ZSI) is a Swiss medical device manufacturer that designs and produces surgical implants for urology, andrology, and gynaecology. Its product range includes artificial urinary sphincters, inflatable and malleable penile implants (including variants specifically engineered for FTM and MTF gender-affirming surgery), and vaginal expanders for cis and trans women. The company sells these implants directly to hospitals and surgeons and through regional distributors.
Is Zephyr Surgical Implants a public or private company?
Zephyr Surgical Implants is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Zephyr Surgical Implants founded?
Zephyr Surgical Implants was founded in 1998. It employs 11 to 50 people.
Where is Zephyr Surgical Implants based?
Zephyr Surgical Implants is headquartered in Les Acacias, Switzerland, in the Europe region.
How does Zephyr Surgical Implants make money?
One revenue line is on record: medical Device Sales.
Who are Zephyr Surgical Implants's main competitors?
Broad incumbents on record are Boston Scientific, Coloplast, Cook Medical and Integra LifeSciences. Direct peers are Rigicon, Promedon, ZSI 100 (Shah Silicone), Silimed and Lepu Medical. KARL STORZ is listed as an others.
Does Zephyr Surgical Implants have an API?
No public API is recorded for Zephyr Surgical Implants.